Insider trade

Director sold ~$117K of TECH shares in the open market

Traded Feb 17, 2026 · Filed Feb 19, 2026

Bio-TechneTECH

~$117K
Reported value · 1,976 sh @ $59.105: 200
Holds after · shares reported: +23.8%
stock since the trade · S&P 500 +11.9%, $58.50 → $72.40 on Oct 1

Why it stands out

A board member of Bio-Techne sold $117K of Bio-Techne shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 17, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 19, 2026

DirectorIndirect holding$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$116,791

Shares × reported transaction price

Timing vs results

13 days after results of Feb 4, 2026, 78 days before results of May 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $58.50 on Feb 17, 2026, 25% above its 52-week low and 18% below its high, after a 2% drop over the previous 30 trading days

52-week range $46.66 (May 21, 2025) to $71.375 (Jan 21, 2026), 48% of the way up, from 251 adjusted closes. 30 trading days earlier: $59.65 on Jan 2, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+2.6%	-0.5%	+3.1%
30 days	-9.6%	-4.9%	-4.7%
90 days	-17.6%	+7.7%	-25.4%
180 days	+26.0%	+11.6%	+14.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0000914190-26-000030
Filed / recorded: Feb 19, 2026, 9:57 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: BIO-TECHNE Corp
Issuer CIK: 842023
Ticker: TECH
Reporting person: Amy E. Herr
Relationship: Director
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 17, 2026
Transaction code: S
Shares / units: 1,976
Price per share: $59.105
Acquired / disposed: Disposed (D)
Shares owned after: 200
Ownership form: Indirect — By significant other
Amendment: No

Footnotes from the filing

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.091 to $59.1390, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.